{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:28:54Z","timestamp":1769725734824,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biologicals.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T18:24:16Z","timestamp":1625768656000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Glycoconjugation of Shigella flexneri type 2a O-polysaccharide with CRM197 as a potential vaccine candidate for shigellosis"],"prefix":"10.1016","volume":"72","author":[{"given":"P.V.S.L.S.S.","family":"Narayana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayati Ray","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-12-220","article-title":"Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review","volume":"12","author":"Fischer","year":"2012","journal-title":"BMC Publ Health"},{"issue":"6","key":"10.1016\/j.biologicals.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11908-014-0408-y","article-title":"Recent advances in understanding the longterm sequelae of childhood infectious diarrhea","volume":"16","author":"Scharf","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"9888","key":"10.1016\/j.biologicals.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biologicals.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to Shigella and enterotoxigenic Escherichia coli diarrhoea: the global burden of disease study 1990\u2013 2016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.biologicals.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/14787210.2015.983902","article-title":"Treatment of drug-resistant Shigella infections","volume":"13","author":"Klontz","year":"2015","journal-title":"Expert Rev Anti Infect"},{"key":"10.1016\/j.biologicals.2021.07.001_bib6","series-title":"Guidelines for the control of epidemics due to Shigella dysenteriae type 1","author":"World Health Organization","year":"1988"},{"issue":"93","key":"10.1016\/j.biologicals.2021.07.001_bib7","first-page":"153","article-title":"Typhoid vaccines: WHO position paper","volume":"13","author":"World Health Organization (WHO)","year":"2018","journal-title":"Epidemiol Rec"},{"issue":"2","key":"10.1016\/j.biologicals.2021.07.001_bib8","article-title":"Estimating diarrheal illness and deaths attributable to Shigella and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa","volume":"8","author":"Lambent","year":"2014","journal-title":"PLoS Neglected Trop Dis"},{"issue":"50","key":"10.1016\/j.biologicals.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1016\/j.vaccine.2017.10.011","article-title":"WHO ETEC & Shigella vaccine consultation expert group","volume":"37","author":"Hosangadi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijbiomac.2020.04.046","article-title":"Epiphanies of well-known and newly discovered macromolecular carbohydrates \u2013 a review","volume":"156","author":"Priscilla","year":"2020","journal-title":"Int J Biol Macromol"},{"issue":"26","key":"10.1016\/j.biologicals.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biologicals.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14712598.2012.725718","article-title":"Glycoconjugate vaccines","volume":"13","author":"Pace","year":"2013","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.biologicals.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.ijbiomac.2014.10.026","article-title":"Nanoparticle and polysaccharide conjugate: a potential candidate vaccine to improve immunological stimuli","volume":"72","author":"Sanjana","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biologicals.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijbiomac.2018.10.122","article-title":"A new functional protein polysaccharide conjugate based on protein concentrate from sesame processing by-products: functional and physico-chemical properties","volume":"122","author":"Aida","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biologicals.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijbiomac.2014.05.065","article-title":"Enzyme\u2013polysaccharide interaction: a method for improved stability of horseradish peroxidase","volume":"69","author":"Lalit","year":"2014","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"10.1016\/j.biologicals.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00284-019-01780-y","article-title":"Enhanced Production of Shigella flexneri Polysaccharide from a newly devised silicate method as a potential vaccine conjugate","volume":"76","author":"Narayana","year":"2019","journal-title":"Curr Microbiol"},{"issue":"12","key":"10.1016\/j.biologicals.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/iai.59.12.4450-4458.1991","article-title":"Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid","volume":"59","author":"Chu","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/iai.64.10.4074-4077.1996","article-title":"Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers","volume":"64","author":"Cohen","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/c3sc50862e","article-title":"Synthetically defined glycoprotein vaccines: current status and future directions","volume":"4","author":"Adamo","year":"2013","journal-title":"Chem Sci"},{"key":"10.1016\/j.biologicals.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","article-title":"A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection","volume":"182","author":"Phalipon","year":"2009","journal-title":"J Immunol"},{"issue":"14","key":"10.1016\/j.biologicals.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.biologicals.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.biologicals.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Br\u00f6ker","year":"2011","journal-title":"Biologicals"},{"issue":"27","key":"10.1016\/j.biologicals.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM197 conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biologicals.2021.07.001_bib26","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines","volume":"38","author":"Ravi","year":"2018","journal-title":"Biosci Rep"},{"issue":"2","key":"10.1016\/j.biologicals.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(87)81060-8","article-title":"Conformational changes in diphtheria toxoids. Analysis with monoclonal antibodies","volume":"218","author":"Bigio","year":"1987","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.biologicals.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/iai.65.6.2088-2093.1997","article-title":"Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker","volume":"65","author":"Kossaczka","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.biologicals.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpba.2017.02.042","article-title":"Determination of free polysaccharide in Vi glycoconjugate vaccine against typhoid fever","volume":"139","author":"Giannelli","year":"2017","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"4","key":"10.1016\/j.biologicals.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.biologicals.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1314476110","article-title":"Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meninngococal serogroup","volume":"110","author":"Micoli","year":"2013","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"2","key":"10.1016\/j.biologicals.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","article-title":"Vaccines based on the cell surface carbohydrates of pathogenic bacteria","volume":"77","author":"Jones","year":"2005","journal-title":"An Acad Bras Cienc"},{"issue":"3B","key":"10.1016\/j.biologicals.2021.07.001_bib34","article-title":"Trypan blue exclusion test of cell viability","volume":"21","author":"Strober","year":"2001","journal-title":"Curr Protoc Im"},{"issue":"456","key":"10.1016\/j.biologicals.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aat4615","article-title":"Glycoconjugate vaccines: principles and mechanisms","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biologicals.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/314759","article-title":"The Israel Pediatric Shigella Study Group. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children","volume":"179","author":"Ashkenazi","year":"1999","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.biologicals.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/iai.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","volume":"61","author":"Taylor","year":"1993","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.biologicals.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal Salmonellae and Shigellae may Be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.biologicals.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acs.bioconjchem.5b00617","article-title":"A synthetic carbohydrate conjugate vaccine candidate against shigellosis: improved bioconjugation and impact of alum on immunogenicity","volume":"27","author":"Robert","year":"2016","journal-title":"Bioconjugate Chem"},{"issue":"3","key":"10.1016\/j.biologicals.2021.07.001_bib40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/IAI.03079-14","article-title":"Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium","volume":"83","author":"Rondini","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.07.001_bib41","author":"World Health Organization"},{"issue":"11","key":"10.1016\/j.biologicals.2021.07.001_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047039","article-title":"O:2-CRM197 conjugates against Salmonella Paratyphi A","volume":"7","author":"Micoli","year":"2012","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.biologicals.2021.07.001_bib43","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/iai.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide\u2013protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.biologicals.2021.07.001_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/molecules23061451","article-title":"Protein carriers for glycoconjugate vaccines: history, selection criteria, characterization and new trends","volume":"23","author":"Micoli","year":"2018","journal-title":"Molecules"},{"issue":"3\u20134","key":"10.1016\/j.biologicals.2021.07.001_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vaccine.2003.08.008","article-title":"Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by highperformance anion-exchange chromatography with conductivity detection (HPAEC\u2013CD)","volume":"22","author":"Kao","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biologicals.2021.07.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biotechadv.2015.11.005","article-title":"Clarification of vaccines: an overview of filter based technology trends and best practices","volume":"34","author":"Lis","year":"2016","journal-title":"Biotechnol Adv"},{"issue":"19\u201320","key":"10.1016\/j.biologicals.2021.07.001_bib47","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(02)00183-4","article-title":"Development of a high-performance anion-exchange chromatography with pulsed-amperometric detection based quantification assay for pneumococcal polysaccharides and conjugates","volume":"20","author":"Talaga","year":"2002","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.biologicals.2021.07.001_bib48","article-title":"Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.biologicals.2021.07.001_bib49","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/jps.21498","article-title":"Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution","volume":"98","author":"Vessely","year":"2009","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.biologicals.2021.07.001_bib50","author":"WHO guidance on the stability evaluation of vaccines"},{"issue":"6","key":"10.1016\/j.biologicals.2021.07.001_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biologicals.2009.08.013","article-title":"Stability of vaccines \u2013 bridging from stability data to continuous safety and efficacy throughout shelf life \u2013 an always reliable approach?","volume":"37","author":"Pfleiderer","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2021.07.001_bib52","first-page":"7","article-title":"Cell viability analysis using trypan blue: manual and automated methods","volume":"vol. 740","author":"Louis","year":"2011"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:47Z","timestamp":1760922887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105621000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":52,"alternative-id":["S1045105621000580"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.07.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoconjugation of Shigella flexneri type 2a O-polysaccharide with CRM197 as a potential vaccine candidate for shigellosis","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}